课题基金 / 基金详情

Communication of biomarker, genetic, lifestyle risk factor profiles for RA

Communication of biomarker, genetic, lifestyle risk factor profiles for RA
RA 生物标志物、遗传、生活方式风险因素概况的交流
批准号:
8293776
负责人:
ELIZABETH W KARLSON
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2017-06-30

项目摘要

项目成果

ELIZABETH W KARLSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The identification of autoantibodies and cytokines in the serum many years prior to the diagnosis of rheumatoid arthritis (RA) suggests opportunities to prevent disease during the pre-clinical phase. Recent research has led to the recognition that RA develops in individuals with genetic risk factors after exposure to environmental factors, including cigarette smoking, periodontitis, and dietary factors. Having a first degree relative (FDR) with RA increases RA risk 3- to 9-fold compared to that in the general population. Despite the expanding knowledge of individual risk factors in the development of RA, there have been no studies of how best to communicate biomarker, genetic and lifestyle risk profiles for a given individual to enable personalized prevention of RA. Given the recent emergence of effective early treatment and the promise of preventive therapies, RA risk prediction now has the potential to avert decades of disability in at-risk patients. In this project, we will build upon our prior discoveries and risk models to develop an online RA risk calculator that combines biomarker, genetic and lifestyle factors. We will then conduct a randomized, controlled trial using this risk calculator in aymptomatic first degree relatives of RA patients in order to test the impact of risk education and counseling upon the readiness to adopt preventive health behaviors. We propose the following specific aims: 1) To develop an online RA risk calculator, a personalized communication tool that includes biomarker, genetic and lifestyle RA risk factors and 2) To conduct a randomized trial of communication of risk factor profiles to first degree relatives of RA patients to test whether use of risk prediction profiles and education will result in change in readiness to undertake behaviors to decrease their RA risk and health behavior change. We will conduct a 3-arm randomized trial, assigning 222 FDRs to receive: (i) a printed pamphlet, (ii) online risk communication or (iii) online risk communication plus health education and counseling. We will follow these groups at 6 weeks, 6 months and 12 months post intervention in order to determine change in behavioral readiness to modify smoking, oral health, or diet behaviors and health behavior change.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
eMERGE Phase IV Clinical Center at Partners HealthCare
  • 批准号:
    10230561
  • 项目类别:
  • 资助金额:
    $88.31万
  • 财政年份:
    2020
  • 负责人:
    ELIZABETH W KARLSON
  • 依托单位:
Joint Biology Consortium Resource-based Center
  • 批准号:
    10281356
  • 项目类别:
  • 资助金额:
    $93.33万
  • 财政年份:
    2016
  • 负责人:
    ELIZABETH W KARLSON
  • 依托单位:
Human Biosamples Core
  • 批准号:
    10281358
  • 项目类别:
  • 资助金额:
    $35.97万
  • 财政年份:
    2016
  • 负责人:
    ELIZABETH W KARLSON
  • 依托单位:
Joint Biology Consortium Resource-based Center
  • 批准号:
    10454986
  • 项目类别:
  • 资助金额:
    $89.32万
  • 财政年份:
    2016
  • 负责人:
    ELIZABETH W KARLSON
  • 依托单位:
海外基金